Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 885 entries
View as:

A Study to Evaluate the Bioavailability and Food Effect of JNJ-39439335 in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01454245 Org: User:
Start: 07/31/11 End: 04/30/12 Due: 04/30/13

A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01640093 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01695135 Org: User:
Start: 08/09/12 End: 05/08/18 Due: 05/08/19

A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma

Phase: N/A Priority: Normal
NCT ID: NCT02933762 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01866033 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2

Phase: N/A Priority: Normal
NCT ID: NCT04611971 Org: User:
Start: 10/27/20 End: 05/06/21 Due: 05/06/22

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03550950 Org: User:
Start: 06/01/18 End: 02/05/19 Due: 02/05/20

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01384630 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

A Study of Nipocalimab in Healthy Male and Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04848558 Org: User:
Start: 05/25/21 End: 05/26/22 Due: 05/26/23

A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

Phase: N/A Priority: Normal
NCT ID: NCT01077362 Org: User:
Start: 03/31/10 End: 11/30/12 Due: 11/30/13

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02397382 Org: User:
Start: 06/18/15 End: 08/31/16 Due: 08/31/17

A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01645280 Org: User:
Start: 08/31/12 End: 05/31/14 Due: 05/31/15

A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02658825 Org: User:
Start: 01/31/16 End: 04/30/16 Due: 04/30/17

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Phase: N/A Priority: Normal
NCT ID: NCT01369342 Org: User:
Start: 07/31/11 End: 10/31/14 Due: 10/31/15

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01582815 Org: User:
Start: 09/30/12 End: 11/30/13 Due: 11/30/14

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT03332459 Org: User:
Start: 01/05/18 End: 04/13/20 Due: 04/13/21

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04006301 Org: User:
Start: 07/26/19 End: 07/13/20 Due: 07/13/21

A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01685983 Org: User:
Start: 08/30/11 End: 03/06/18 Due: 03/06/19

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01203631 Org: User:
Start: 02/28/11 End: 05/31/13 Due: 05/31/14

A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations

Phase: N/A Priority: Normal
NCT ID: NCT02156375 Org: User:
Start: 05/31/14 End: 12/31/14 Due: 12/31/15

A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01508195 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02920424 Org: User:
Start: 06/30/17 End: 09/26/19 Due: 09/26/20

A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4

Phase: N/A Priority: Normal
NCT ID: NCT05522517 Org: User:
Start: 08/22/22 End: 11/02/22 Due: 11/02/23

A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00855361 Org: User:
Start: 07/31/09 End: 12/31/11 Due: 12/31/12

A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01873001 Org: User:
Start: 05/31/13 End: 07/31/13 Due: 07/31/14